Cargando…

A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy

BACKGROUND: More in-depth models, such as biomarker and anatomical information, are needed to predict individualized prognoses of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after curative liver resection. alpha-fetoprotein (AFP) has conflicting value in predicting prognosis. We a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Bai, Chen, Jing-San, Yang, Sheng-Li, Chen, George G., He, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798215/
https://www.ncbi.nlm.nih.gov/pubmed/35116886
http://dx.doi.org/10.21037/tcr.2019.07.49
_version_ 1784641746802573312
author Wei, Bai
Chen, Jing-San
Yang, Sheng-Li
Chen, George G.
He, Hao
author_facet Wei, Bai
Chen, Jing-San
Yang, Sheng-Li
Chen, George G.
He, Hao
author_sort Wei, Bai
collection PubMed
description BACKGROUND: More in-depth models, such as biomarker and anatomical information, are needed to predict individualized prognoses of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after curative liver resection. alpha-fetoprotein (AFP) has conflicting value in predicting prognosis. We aimed to investigate the significance of an AFP score model as a potential predictor of prognosis after radical resection in patients with HBV-related HCC. METHODS: This study retrospectively analyzed 397 patients with HBV-related HCC who underwent hepatic resection between 2001 and 2013. Serum AFP level, tumor size, and tumor number were calculated by adding individual points for the AFP score model. Patient and tumor characteristics were tested for prognostic significance using ANOVA and chi-squared test, respectively. The receiver operating characteristic (ROC) curve was used to identify the AFP score model with or without other risk factors to discriminate patients. Kaplan-Meier and Cox’s analyses were performed to pinpoint risk factors for overall survival (OS) and disease-free survival (DFS) in the patients. RESULTS: The cutoff value for the AFP score model was set at 2 using the ROC curve, with good specificity and sensitivity for OS and DFS. According to the AFP score model, 185 patients were in the AFP score >2 group, and 212 were in the AFP score ≤2 group. The median OS in the AFP score ≤2 and AFP score >2 groups were 173.4±1.00 vs. 50.30±8.67 m, respectively (P=0.000). The median DFS in the AFP score ≤2 and AFP score >2 groups were 17.20±3.66 vs. 73.7±10.39 m (P=0.000), respectively. Analyses from Cox’s multivariate proportional hazard model indicated that AFP score (HR =0.563, 95% CI: 0.398–0.798, P=0.001), MVI (HR =0.653, 95% CI: 0.441–0.967, P=0.033), and cirrhosis (HR =0.358, 95% CI: 0.185–0.696, P=0.002) were risk factors for OS. The multivariate Cox model identified MVI (HR =1.589, 95% CI: 1.496–2.854, P=0.003) and AFP score (HR =0.876, 95% CI: 0.404–0.925, P=0.040) as risk factors of DFS. According to the stratification by the AFP score with MVI, the mean OS in the AFP score >2 group combined with the MVI group was significantly shorter, compared with that in the AFP score >2 group without the MVI group (65.58±9.18 vs. 94.21±8.25 m, P=0.024). The mean OS in the AFP score >2 group combined with the cirrhosis group is significantly shorter than that in the AFP score ≤2 group without the cirrhosis group (64.08±7.38 vs. 145.31±8.38 m, P=0.000). CONCLUSIONS: The AFP score model categorizes HCC patients with relatively good liver function after radical resection with low- and high-risk prognosis.
format Online
Article
Text
id pubmed-8798215
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87982152022-02-02 A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy Wei, Bai Chen, Jing-San Yang, Sheng-Li Chen, George G. He, Hao Transl Cancer Res Original Article BACKGROUND: More in-depth models, such as biomarker and anatomical information, are needed to predict individualized prognoses of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after curative liver resection. alpha-fetoprotein (AFP) has conflicting value in predicting prognosis. We aimed to investigate the significance of an AFP score model as a potential predictor of prognosis after radical resection in patients with HBV-related HCC. METHODS: This study retrospectively analyzed 397 patients with HBV-related HCC who underwent hepatic resection between 2001 and 2013. Serum AFP level, tumor size, and tumor number were calculated by adding individual points for the AFP score model. Patient and tumor characteristics were tested for prognostic significance using ANOVA and chi-squared test, respectively. The receiver operating characteristic (ROC) curve was used to identify the AFP score model with or without other risk factors to discriminate patients. Kaplan-Meier and Cox’s analyses were performed to pinpoint risk factors for overall survival (OS) and disease-free survival (DFS) in the patients. RESULTS: The cutoff value for the AFP score model was set at 2 using the ROC curve, with good specificity and sensitivity for OS and DFS. According to the AFP score model, 185 patients were in the AFP score >2 group, and 212 were in the AFP score ≤2 group. The median OS in the AFP score ≤2 and AFP score >2 groups were 173.4±1.00 vs. 50.30±8.67 m, respectively (P=0.000). The median DFS in the AFP score ≤2 and AFP score >2 groups were 17.20±3.66 vs. 73.7±10.39 m (P=0.000), respectively. Analyses from Cox’s multivariate proportional hazard model indicated that AFP score (HR =0.563, 95% CI: 0.398–0.798, P=0.001), MVI (HR =0.653, 95% CI: 0.441–0.967, P=0.033), and cirrhosis (HR =0.358, 95% CI: 0.185–0.696, P=0.002) were risk factors for OS. The multivariate Cox model identified MVI (HR =1.589, 95% CI: 1.496–2.854, P=0.003) and AFP score (HR =0.876, 95% CI: 0.404–0.925, P=0.040) as risk factors of DFS. According to the stratification by the AFP score with MVI, the mean OS in the AFP score >2 group combined with the MVI group was significantly shorter, compared with that in the AFP score >2 group without the MVI group (65.58±9.18 vs. 94.21±8.25 m, P=0.024). The mean OS in the AFP score >2 group combined with the cirrhosis group is significantly shorter than that in the AFP score ≤2 group without the cirrhosis group (64.08±7.38 vs. 145.31±8.38 m, P=0.000). CONCLUSIONS: The AFP score model categorizes HCC patients with relatively good liver function after radical resection with low- and high-risk prognosis. AME Publishing Company 2019-08 /pmc/articles/PMC8798215/ /pubmed/35116886 http://dx.doi.org/10.21037/tcr.2019.07.49 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Wei, Bai
Chen, Jing-San
Yang, Sheng-Li
Chen, George G.
He, Hao
A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy
title A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy
title_full A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy
title_fullStr A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy
title_full_unstemmed A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy
title_short A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy
title_sort scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis b virus-related hepatocellular carcinoma patients after curative hepatectomy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798215/
https://www.ncbi.nlm.nih.gov/pubmed/35116886
http://dx.doi.org/10.21037/tcr.2019.07.49
work_keys_str_mv AT weibai ascoringmodelcombiningserumalphafetoproteinandtumorsizeandnumberpredictsprognosisinhepatitisbvirusrelatedhepatocellularcarcinomapatientsaftercurativehepatectomy
AT chenjingsan ascoringmodelcombiningserumalphafetoproteinandtumorsizeandnumberpredictsprognosisinhepatitisbvirusrelatedhepatocellularcarcinomapatientsaftercurativehepatectomy
AT yangshengli ascoringmodelcombiningserumalphafetoproteinandtumorsizeandnumberpredictsprognosisinhepatitisbvirusrelatedhepatocellularcarcinomapatientsaftercurativehepatectomy
AT chengeorgeg ascoringmodelcombiningserumalphafetoproteinandtumorsizeandnumberpredictsprognosisinhepatitisbvirusrelatedhepatocellularcarcinomapatientsaftercurativehepatectomy
AT hehao ascoringmodelcombiningserumalphafetoproteinandtumorsizeandnumberpredictsprognosisinhepatitisbvirusrelatedhepatocellularcarcinomapatientsaftercurativehepatectomy
AT weibai scoringmodelcombiningserumalphafetoproteinandtumorsizeandnumberpredictsprognosisinhepatitisbvirusrelatedhepatocellularcarcinomapatientsaftercurativehepatectomy
AT chenjingsan scoringmodelcombiningserumalphafetoproteinandtumorsizeandnumberpredictsprognosisinhepatitisbvirusrelatedhepatocellularcarcinomapatientsaftercurativehepatectomy
AT yangshengli scoringmodelcombiningserumalphafetoproteinandtumorsizeandnumberpredictsprognosisinhepatitisbvirusrelatedhepatocellularcarcinomapatientsaftercurativehepatectomy
AT chengeorgeg scoringmodelcombiningserumalphafetoproteinandtumorsizeandnumberpredictsprognosisinhepatitisbvirusrelatedhepatocellularcarcinomapatientsaftercurativehepatectomy
AT hehao scoringmodelcombiningserumalphafetoproteinandtumorsizeandnumberpredictsprognosisinhepatitisbvirusrelatedhepatocellularcarcinomapatientsaftercurativehepatectomy